StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$16.78−0.40 (-2.33%)

Close on Nov 18, 2026Market cap $1.91BP/E –Yield –

Immunome total assets

Total assets on the balance sheet at the end of each period.

Immunome's total assets was $619.79M at Mar 31, 2026. For fiscal 2025 it was $683.19M, up 184.4% from the year before. The highest annual figure on record is $683.19M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$683.19M+184.4%
FY2024Dec 31, 2024$240.24M+61.7%
FY2023Dec 31, 2023$148.54M+517.7%
FY2022Dec 31, 2022$24.05M-58.5%
FY2021Dec 31, 2021$57.93M+30.1%
FY2020Dec 31, 2020$44.53M+779.9%
FY2019Dec 31, 2019$5.06M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$619.79M+80.9%
Q4 FY2025Dec 31, 2025$683.19M+184.4%
Q3 FY2025Sep 30, 2025$299.38M+16.5%
Q2 FY2025Jun 30, 2025$296.29M+0.0%
Q1 FY2025Mar 31, 2025$342.69M+7.2%
Q4 FY2024Dec 31, 2024$240.24M+61.7%
Q3 FY2024Sep 30, 2024$256.90M+175.8%
Q2 FY2024Jun 30, 2024$296.22M+614.9%
Q1 FY2024Mar 31, 2024$319.75M+564.6%
Q4 FY2023Dec 31, 2023$148.54M+517.7%
Q3 FY2023Sep 30, 2023$93.16M+205.0%
Q2 FY2023Jun 30, 2023$41.44M+6.2%
Q1 FY2023Mar 31, 2023$48.11M+0.8%
Q4 FY2022Dec 31, 2022$24.05M-58.5%
Q3 FY2022Sep 30, 2022$30.55M-51.2%
Q2 FY2022Jun 30, 2022$39.02M-39.2%
Q1 FY2022Mar 31, 2022$47.73M+12.1%
Q4 FY2021Dec 31, 2021$57.93M+30.1%
Q3 FY2021Sep 30, 2021$62.56M+422.1%
Q2 FY2021Jun 30, 2021$64.14M+1167.6%
Q1 FY2021Mar 31, 2021$42.59M–
Q4 FY2020Dec 31, 2020$44.53M–
Q3 FY2020Sep 30, 2020$11.98M–
Q4 FY2019Dec 31, 2019$5.06M–

More Immunome figures

See a number that looks wrong?